JACOBS LEVY EQUITY MANAGEMENT, INC - 4D MOLECULAR THERAPEUTICS IN ownership

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 64 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$626,000
-30.5%
89,641
+139.6%
0.01%
-16.7%
Q2 2021$901,00037,4170.01%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
VR Adviser, LLC 3,000,000$38,190,0004.02%
Casdin Capital, LLC 1,033,811$13,160,4141.46%
BVF INC/IL 4,007,413$51,014,3671.38%
Deep Track Capital, LP 2,778,107$35,365,3021.36%
Opaleye Management Inc. 308,500$3,927,2051.28%
Eagle Health Investments LP 437,911$5,574,6071.23%
Novo Holdings A/S 1,200,000$15,276,0001.13%
RA Capital Management 4,163,211$52,997,6761.04%
VIKING GLOBAL INVESTORS LP 4,787,914$60,950,1450.25%
HighVista Strategies LLC 33,419$425,4240.20%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders